Form 4: Dynatrace Director Sells Shares After RSU Vesting

Dynatrace Director Lisa M Campbell sold 253 shares of common stock for $44.24 per share following the vesting of 506 restricted stock units.

Summary

• Lisa M Campbell, a Director at Dynatrace, Inc., reported transactions involving the company's common stock and restricted stock units (RSUs).
• On December 4, 2025, 506 time-based RSUs vested, converting into 506 shares of Dynatrace common stock.
• These RSUs were part of a grant made on September 4, 2024, with 25% vesting on September 4, 2025, and the remainder vesting quarterly until September 4, 2028, subject to continued service.
• Following the vesting, Campbell beneficially owned 1,518 shares of common stock and 5,568 RSUs.
• On December 5, 2025, Campbell sold 253 shares of common stock at a price of $44.24 per share.
• This sale was executed under a Rule 10b5-1 trading plan adopted on May 16, 2025.
• After the reported transactions, Campbell beneficially owns 1,265 shares of common stock and 5,568 RSUs.

Sentiment

Score: 5

Explanation: Neutral. A Form 4 filing is a factual report of insider transactions. The sale was pre-planned under a 10b5-1 plan, which mitigates negative sentiment often associated with insider sales, as it suggests a pre-determined liquidity event rather than a reaction to new negative information.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned transaction rather than an immediate reaction to new information, which can mitigate concerns about insider selling.

Negatives

• A director selling shares, even under a pre-planned arrangement, could be perceived negatively by some investors, though it is a common practice for liquidity or tax purposes.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance, as it is a transactional report for an insider.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity and does not provide information directly related to broader industry trends or the competitive landscape. Insider sales, especially those under 10b5-1 plans, are common for liquidity or diversification purposes and typically do not reflect a change in the company's fundamental outlook.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4) and does not contain information that allows for a direct comparison to industry-specific operational or financial benchmarks.
• Insider trading activity is common across all industries, and sales under Rule 10b5-1 plans are a standard practice for executives to manage their equity holdings in a compliant manner, similar to practices observed at companies like Microsoft (MSFT) or Apple (AAPL) where executives regularly sell vested shares.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be viewed as a minor signal, but the pre-planned nature (10b5-1) typically reduces concerns about the underlying health or prospects of the company.

Next Steps

• Remaining RSUs will continue to vest in equal quarterly installments until September 4, 2028, subject to Lisa M Campbell's continued service as a director.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director sold a portion of shares acquired through RSU vesting, executed under a pre-established Rule 10b5-1 trading plan. Such transactions are common for liquidity or diversification and typically do not indicate a change in the company's fundamental prospects or warrant a change in investment recommendation based solely on this filing. Investors should 'hold' and monitor broader company performance and market conditions.

Keywords

Dynatrace, DT, Form 4, Insider Trading, Stock Sale, RSU Vesting, Lisa M Campbell, Director, Rule 10b5-1